Yahoo! Finance: WYE News

Pfizer says FDA is still reviewing Prevnar 13 (AP)

Wed, 30 Dec 2009 22:21:12 Etc/GMT

Pfizer Inc. says the Food and Drug Administration is again extending its review of Prevnar 13, a children's pneumococcal vaccine.

TTP 'blunders' into product manufacture (at FT.com)

Wed, 30 Dec 2009 17:40:27 Etc/GMT

Inside a large building just outside Cambridge, a team of engineers are building what amounts to giant vending machines for chemicals - refrigerated boxes each with room for 150,000 samples that are used in laboratory experiments.

Pfizer spent $5.4M lobbying government in 3Q (AP)

Wed, 23 Dec 2009 23:18:26 Etc/GMT

Pfizer Inc., the world's biggest drugmaker, spent $5.4 million lobbying the government in the third quarter on topics including the health care overhaul, government spending on medication, and patent and trade issues, according to a quarterly disclosure report.

Bankers turn bullish about bid activity (at FT.com)

Wed, 23 Dec 2009 21:20:23 Etc/GMT

It did not take long for mergers and acquisitions bankers to start talking up a recovery. Following two years of depressed levels of worldwide deal activity, bankers have turned bullish about a pick-up next year, encouraged by rising equity markets and lower valuations.

Sanofi-Aventis to buy Gold Bond maker Chattem (AP)

Mon, 21 Dec 2009 18:24:09 Etc/GMT

French drugmaker Sanofi-Aventis SA said Monday it plans to buy U.S. health-care company Chattem Inc., maker of over-the-counter mainstays like Gold Bond skin products, for $1.9 billion in cash.

UPDATE - Sanofi aims to double vaccine sales by 2013 (at Reuters)

Thu, 17 Dec 2009 14:58:26 Etc/GMT

[$$] Pfizer Eyes China Growth (at The Wall Street Journal Online)

Wed, 16 Dec 2009 18:01:04 Etc/GMT

Menopause, as Brought to You by Big Pharma (at The New York Times)

Tue, 15 Dec 2009 19:52:06 Etc/GMT

Pfizer children's vaccine receives European OK (AP)

Fri, 11 Dec 2009 12:54:43 Etc/GMT

Pfizer Inc. said Friday European regulators have approved a new version of its children's pneumococcal vaccine, Prevenar 13.

Glaxo, Wyeth Cut Costs With Trial Software (at TheStreet.com)

Fri, 11 Dec 2009 10:00:00 Etc/GMT

Pfizer extends medication giveaway for jobless (AP)

Thu, 10 Dec 2009 19:03:03 Etc/GMT

Drugmaker Pfizer Inc. said Thursday it will extend for another year a program that provides free prescription medications to people who have lost their jobs.

Pfizer rises as analyst expects dividend increase (AP)

Wed, 9 Dec 2009 17:00:59 Etc/GMT

Shares of Pfizer Inc. rose Wednesday after a Credit Suisse analyst said the world's largest drugmaker is likely to raise its dividend up to 20 percent later this month, less than a year after slashing its payout.

Should Amgen Buy Human Genome Sciences? (at Forbes.com)

Thu, 3 Dec 2009 19:06:36 Etc/GMT

A Look Inside Paulson's Investor Letter (at Seeking Alpha)

Thu, 3 Dec 2009 07:56:55 Etc/GMT

Calif. insurers say $12 billion invested in Iran (AP)

Wed, 2 Dec 2009 05:01:03 Etc/GMT

California's insurance commissioner said Tuesday he will push insurance companies doing business in California to divest up to $12 billion in indirect investments in Iran's defense, nuclear, energy and banking industries.

Protalix shares fall following Pfizer deal (AP)

Tue, 1 Dec 2009 19:07:12 Etc/GMT

Shares of Protalix BioTherapeutics Inc. fell Tuesday as a newly announced licensing deal with Pfizer Inc. appeared to dispel hopes of a buyout.

Experienced Small Cap Portfolio Manager Priced Fair Market Value For IMS Health At $17 To $18 Per Share (Wall Street Transcript)

Mon, 30 Nov 2009 18:16:00 Etc/GMT

12 Years Of Patent Protection For Biologics Based Research And Development Creates Buying Opportunity In Biotech Stocks (Wall Street Transcript)

Sat, 28 Nov 2009 15:34:00 Etc/GMT

67 WALL STREET, New York - November 28, 2009 - The Wall Street Transcript has recently published its Q4 2009 Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

The fall of the world's best-selling drug (at FT.com)

Sat, 28 Nov 2009 00:30:50 Etc/GMT

Every day, Jeffrey Kindler swallows a bittersweet, oval pill that helps dictate his fate. It offers hope of extending his life for many years, while reminding him that the direct boost it gives his wealth is coming swiftly to an end.

3 generations of Wyeths to be sold in NYC (AP)

Tue, 24 Nov 2009 22:54:48 Etc/GMT

Three generations of Wyeth artworks will be auctioned next month, including 14 original oil canvases by N.C. Wyeth that were used to lavishly illustrate the classic adventure tale of "Robinson Crusoe."